Last login 02-Mar-2021
Total Post 28
Score 1035

User Posts

The antibody discovery services market is estimated to be worth around USD 6.5 billion ...

Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector i...

The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roo...

With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies a...

The market opportunity for AR / VR based healthcare digital marketing service

Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experienti...

contract manufacturing market for Pharmaceuticals in China

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attr...

global digital biomarkers market is projected to be worth over USD 22 billion by 2030

Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myr...

Growing at an annualized rate of over 9%, the antibody discovery services market is pro...

High target specificity and favorable safety profiles offered by antibody based pharmacological interventions has created a high demand for such mo...

The High Energy / Hazardous Chemistry-based API manufacturing services market is estima...

Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of...

The diabetes drug delivery devices market is estimated to be worth USD 31 billion in 20...

Owing to over a decade of extensive R&D, the novel diabetes drug delivery devices, such as insulin pumps and pen-injectors, offer a safe and conven...

The antibody contract manufacturing market is estimated to be worth USD 17 billion in 2...

The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new...

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in...

detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics

12